Drug-Device Combination Products for the Warfighter: From Development to Fielded Medical Countermeasure
A drug-device combination product for the warfighter has to work in extreme environments, satisfy FDA expectations for both the drug and the device, and rest on manufacturing and quality infrastructure that can supply it for years. Brian Wayman, Senior Director of Combination Product Development and Global Health Security Lead, and Katrina Spencer, Director of Combination Product Development at Kindeva Drug Delivery, will share practical lessons on device design, development planning, regulatory strategy, and manufacturing readiness, drawing on real-world examples and case studies.
Their perspective comes from Kindeva’s subsidiary Meridian Medical Technologies, which pioneered the emergency-use autoinjector more than 60 years ago and has since developed and deployed more than 100 million MCM and emergency-use drug-device combination products for military and civilian use. If your therapeutic or countermeasure candidate will eventually need a delivery device, a regulatory path, and a manufacturing partner, this session lays out that route from a team that has traveled it many times. Forty minutes of content followed by twenty minutes of discussion and Q&A.
Registration – https://us06web.zoom.us/meeting/register/jKaU2edURbmM3TQTNJWfzw